secwatch.observer — SEC 8-K summary
======================================

Issuer:     BullFrog AI Holdings, Inc. (BFRG)
CIK:        0001829247
Form:       8-K
Filed at:   2023-10-20T23:59:59+00:00
Accession:  0001493152-23-037840
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bullfrog AI enters commercial agreement with Lieber Institute to commercialize AI-derived brain data products
--------------------------------------------------------------------------------

- Entered commercial agreement with Lieber Institute for Brain Development to commercialize AI/ML products from LIBD brain data.
- BFAI granted exclusive worldwide license to develop, sell Licensed Products in drug development field (therapeutic, target ID, patient selection).
- BFAI to pay LIBD royalty on Net Sales (rates redacted); exclusivity ends if no First Commercial Sale within 2 years of listing.
- LIBD may change license to non-exclusive after 3 years from First Commercial Sale, adjusting royalty rate.
- LIBD receives Licensed Products free for internal research; if LIBD commercializes, pays BFAI 70% of Net Sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829247/000149315223037840/0001493152-23-037840-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829247/000149315223037840/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037840

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer